Literature DB >> 18808324

Statins in endothelial signaling and activation.

Jeffrey R Jacobson1.   

Abstract

The beneficial effects of statins, the most widely prescribed class of drugs in the world, are now recognized to extend well beyond their lipid-lowering properties. Through a combination of both distinct and interdependent effects on endothelial cell (EC) Rho GTPase regulation, NAPDH oxidase activity, NO bioavailability, and differential gene expression, statins confer significant protection of the vasculature. Abundant in vitro data, in addition to myriad reports relying on a range of animal models, now firmly support the idea that these drugs may serve as novel and effective therapeutic agents in a variety of disease states characterized by vascular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18808324      PMCID: PMC6463996          DOI: 10.1089/ars.2008.2284

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  16 in total

1.  Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.

Authors:  David Guillén; Federico Cofán; Emilio Ros; Olga Millán; Montse Cofán; Mercè Brunet
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

2.  Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium.

Authors:  Yu-Miao Wei; Xiang Li; Jing Xiong; Justine M Abais; Min Xia; Krishna M Boini; Yang Zhang; Pin-Lan Li
Journal:  J Pharmacol Exp Ther       Date:  2013-02-22       Impact factor: 4.030

Review 3.  Endothelial cell metabolism in normal and diseased vasculature.

Authors:  Guy Eelen; Pauline de Zeeuw; Michael Simons; Peter Carmeliet
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 4.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

5.  Gaseotransmitters: new frontiers for translational science.

Authors:  Csaba Szabo
Journal:  Sci Transl Med       Date:  2010-11-24       Impact factor: 17.956

Review 6.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

7.  Statins as first-line therapy for acute coronary syndrome?

Authors:  Petr Ostadal
Journal:  Exp Clin Cardiol       Date:  2012

8.  Activation of NFkB and coagulation in lung injury by hyperoxia and excessive mechanical ventilation: one more reason "low and slow" is the way to go?

Authors:  Jeffrey R Jacobson; Konstantin G Birukov
Journal:  Transl Res       Date:  2009-08-25       Impact factor: 7.012

9.  Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes.

Authors:  Yu-Miao Wei; Xiang Li; Ming Xu; Justine M Abais; Yang Chen; Christopher R Riebling; Krishna M Boini; Pin-Lan Li; Yang Zhang
Journal:  Cell Physiol Biochem       Date:  2013-06-18

Review 10.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.